2,789
Views
14
CrossRef citations to date
0
Altmetric
Review

Proteomic studies of common chronic pain conditions - a systematic review and associated network analyses

ORCID Icon &

References

  • Bennett DL, Woods CG. Painful and painless channelopathies. Lancet Neurol. 2014;13(6):587–599.
  • Tracey I, Woolf CJ, Andrews NA. Composite pain biomarker signatures for objective assessment and effective treatment. Neuron. 2019;101(5):783–800.
  • Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287–333.
  • Bergman S. Chronic musculoskeletal pain: a multifactorial process. (Ed.^(Eds). Lund: Lund University; 2001.
  • Fillingim RB. Individual differences in pain: understanding the mosaic that makes pain personal. Pain. 2017;158(Suppl 1):S11–S8.
  • Lidgren L. Preface: neck pain and the decade of the bone and joint 2000–2010. Spine (Phila Pa 1976). 2008;33(4S):S1–S2.
  • Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015;49. DOI:10.1590/S0034-8910.2015049005874
  • Fejer R, Kyvik KO, Hartvigsen J. The prevalence of neck pain in the world population: a systematic critical review of the literature. Eur Spine J. 2006;15(6):834–848.
  • Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380–387.
  • Gerdle B, Bjork J, Coster L, et al. Prevalence of widespread pain and associations with work status: a population study. BMC Musculoskelet Disord. 2008;9:102.
  • Coster L, Kendall S, Gerdle B, et al. Chronic widespread musculoskeletal pain - A comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain. 2008;12(5):600–610.
  • Henriksson CM, Liedberg GM, Gerdle B. Women with fibromyalgia: work and rehabilitation. Disabil Rehabil. 2005;27(12):685–694.
  • Wolfe F, Smythe HA, Yunus MB, et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 1990;33(2):160–172.
  • Larsson B, Sogaard K, Rosendal L. Work related neck-shoulder pain: a review on magnitude, risk factors, biochemical characteristics, clinical picture and preventive interventions. Best Pract Res Clin Rheumatol. 2007;21(3):447–463.
  • Larsson B, Bjork J, Borsbo B, et al. A systematic review of risk factors associated with transitioning from regional musculoskeletal pain to chronic widespread pain. Eur J Pain. 2012;16(8):1084–1093.
  • The International Association for the Study of Pain (IASP). IASP Terminology. IASP; 2020 [cited 2020 Jul 15]. Available from: https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698#Pain
  • Aydede M. Does the IASP definition of pain need updating? Pain Rep. 2019;4(5):e777.
  • Vardeh D, Mannion RJ, Woolf CJ. Toward a mechanism-based approach to pain diagnosis. J Pain. 2016;17(9 Suppl):T50–69.
  • Sommer C, Leinders M, Uceyler N. Inflammation in the pathophysiology of neuropathic pain. Pain. 2018;159(3):595–602.
  • Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet. 2011;377(9784):2226–2235.
  • Hauser W, Walitt B, Fitzcharles MA, et al. Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther. 2014;16(1):201.
  • Nijs J, Kosek E, Van Oosterwijck J, et al. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise? Pain Physician. 2012;15(3 Suppl):ES205–13.
  • Zanin M, Chorbev I, Stres B, et al. Community effort endorsing multiscale modelling, multiscale data science and multiscale computing for systems medicine. Brief Bioinform. 2017.
  • Khan AN, Jacobsen HE, Khan J, et al. Inflammatory biomarkers of low back pain and disc degeneration: a review. Ann N Y Acad Sci. 2017;1410(1):68–84.
  • Langhauser F, Casas A, Dao V, et al. A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection. NPJ Syst Biol Appl. 2018;4:8.
  • Petersel D, Dror V, Cheung R. Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res. 2011;89(1):29–34.
  • Smith H, Harris R, Clauw D. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician. 2011;14(2):E217–45.
  • Henry DE, Chiodo AE, Yang W. Central nervous system reorganization in a variety of chronic pain states: a review. Pm R. 2011;3(12):1116–1125.
  • Nakamura Y, Nojiri K, Yoshihara H, et al. Significant differences of brain blood flow in patients with chronic low back pain and acute low back pain detected by brain SPECT. J Orthop Sci. 2014;19:384–389.
  • Ung H, Brown JE, Johnson KA, et al. Multivariate classification of structural MRI data detects chronic low back pain. Cereb Cortex. 2014;24(4):1037–1044.
  • Hong JY, Labus JS, Jiang Z, et al. Regional neuroplastic brain changes in patients with chronic inflammatory and non-inflammatory visceral pain. PLoS One. 2014;9(1):e84564.
  • Moayedi M, Weissman-Fogel I, Salomons TV, et al. Abnormal gray matter aging in chronic pain patients. Brain Res. 2012;1456:82–93.
  • Phillips K, Clauw DJ. Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum. 2013;65(2):291–302.
  • Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc. 1999;74:385–398.
  • Staud R. The role of peripheral input for chronic pain syndromes like fibromyalgia syndrome. J Musculoskelet Pain. 2008;16(1–2):67–74.
  • Seminowicz DA, Wideman TH, Naso L, et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J Neurosci. 2011;31(20):7540–7550.
  • Rodriguez-Raecke R, Niemeier A, Ihle K, et al. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci. 2009;29(44):13746–13750.
  • Rodriguez-Raecke R, Niemeier A, Ihle K, et al. Structural brain changes in chronic pain reflect probably neither damage nor atrophy. PLoS One. 2013;8(2):e54475.
  • Gerdle B, Ghafouri B, Ernberg M, et al. Chronic musculoskeletal pain: review of mechanisms and biochemical biomarkers as assessed by the microdialysis technique. J Pain Res. 2014;7:313–326.
  • Gerdle B, Larsson B. Potential muscle biomarkers of chronic myalgia in humans - a systematic review of microdialysis studies. In: Khan T, editor. Biomarker. Rijeka (Croatia): INTECH open Access publisher; 2012. p. 103–132.
  • Gerdle B, Forsgren M, Bengtsson A, et al. Decreased muscle concentrations of ATP and PCR in the quadriceps muscle of fibromyalgia patients - a 31P MRS study. Eur J Pain. 2013;17: 12-5-1215.
  • Park JH, Phothimat P, Oates CT, et al. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum. 1998;41(3):406–413.
  • Chizh BA, Greenspan JD, Casey KL, et al. Identifying biological markers of activity in human nociceptive pathways to facilitate analgesic drug development. Pain. 2008;140(2):249–253.
  • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
  • Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–466.
  • Chalmers D. The puzzle of conscious experience. Sci Am. 1995;273(6):80–86.
  • Peressini A. Blurring two conceptions of subjective: folk versus philosophical phenomenality. Philos Psychol. 2014;27(6):862–889.
  • Ramirez-Tejero JA, Martinez-Lara E, Rus A, et al. Insight into the biological pathways underlying fibromyalgia by a proteomic approach. J Proteomics. 2018;186:47–55.
  • Suppers A, van Gool AJ, Wessels H. Integrated chemometrics and statistics to drive successful proteomics biomarker discovery. Proteomes. 2018;6:2.
  • Baskin II, Winkler D, Tetko IV. A renaissance of neural networks in drug discovery. Expert Opin Drug Discov. 2016;11(8):785–795.
  • Pavlou MP, Diamandis EP, Blasutig IM. The long journey of cancer biomarkers from the bench to the clinic. Clin Chem. 2013;59(1):147–157.
  • Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291(5507):1304–1351.
  • Schwanhausser B, Busse D, Li N, et al. Global quantification of mammalian gene expression control. Nature. 2011;473(7347):337–342.
  • Manzoni C, Kia DA, Vandrovcova J, et al. Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences. Brief Bioinform. 2018;19(2):286–302.
  • Sommer C. Exploring pain pathophysiology in patients. Science. 2016;354(6312):588–592.
  • Gazerani P, Vinterhoj H. `Omics´: an emerging field in pain research and management. Future Neurol. 2016;11(4):255–265.
  • O’Farrell P. High resolution two-dimensional electrophoresis of proteins. JBC. 1975;250(10):4007–4021.
  • Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics. 2002;2(1):3–10.
  • Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis. 1995;16(6):1034–1059.
  • Yates JR 3rd. Mass spectrometry and the age of the proteome. J Mass Spectrom. 1998;33(1):1–19.
  • Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198–207.
  • Cox J, Hein MY, Luber CA, et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13(9):2513–2526.
  • National Center for Biotechnology Information (NCBI). Proteins. 2020 [cited 2020 Jul 15]. Available from: https://www.ncbi.nlm.nih.gov/guide/proteins/
  • UniProt Consortium. UniProtKb. 2020 [cited 2020 Jul 15]. Available from: https://www.uniprot.org/
  • Hoopmann MR, Moritz RL. Current algorithmic solutions for peptide-based proteomics data generation and identification. Curr Opin Biotechnol. 2013;24(1):31–38.
  • Nesvizhskii AI. A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics. J Proteomics. 2010;73(11):2092–2123.
  • Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D13.
  • Gomez-Varela D, Barry AM, Schmidt M. Proteome-based systems biology in chronic pain. J Proteomics. 2019;190:1–11.
  • Muller T, Schrotter A, Loosse C, et al. Sense and nonsense of pathway analysis software in proteomics. J Proteome Res. 2011;10(12):5398–5408.
  • Crosara KTB, Moffa EB, Xiao Y, et al. Merging in-silico and in vitro salivary protein complex partners using the STRING database: a tutorial. J Proteomics. 2018;171:87–94.
  • Gomez-Varela D, Schmidt M. Exploring novel paths towards protein signatures of chronic pain. Mol Pain. 2016;12:174480691667965.
  • Gomez-Varela D, Schmidt M, editors. The proteomics and metabolomics of pain—opportunities for systems medicine. Oxford: Oxford University Press; 2018.
  • Haynes PA, Stein SE, Washburn MP. Data quality issues in proteomics - there are many paths to enlightenment. Proteomics. 2016;16(18):2433–2434.
  • Ciregia F, Giacomelli C, Giusti L, et al. Putative salivary biomarkers useful to differentiate patients with fibromyalgia. J Proteomics. 2019;190:44–54.
  • Khoonsari PE, Musunri S, Herman S, et al. Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patients. J Proteomics. 2019;190:35–43.
  • Lind AL, Just D, Mikus M, et al. CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia. J Pain Res. 2019;12:2875–2889.
  • Farajzadeh A, Bathaie SZ, Arabkheradmand J, et al. Different pain states of trigeminal neuralgia make significant changes in the plasma proteome and some biochemical parameters: a preliminary cohort study. J Mol Neurosci. 2018;66(4):524–534.
  • Liu XD, Zeng BF, Xu JG, et al. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics. 2006;6(3):1019–1028.
  • Conti A, Ricchiuto P, Iannaccone S, et al. Pigment epithelium-derived factor is differentially expressed in peripheral neuropathies. Proteomics. 2005;5(17):4558–4567.
  • Backryd E, Ghafouri B, Carlsson AK, et al. Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study. J Pain Res. 2015;8:321–333.
  • Olausson P, Gerdle B, Ghafouri N, et al. Identification of proteins from interstitium of trapezius muscle in women with chronic myalgia using microdialysis in combination with proteomics. PLoS One. 2012;7(12):e52560.
  • Hadrevi J, Ghafouri B, Larsson B, et al. Multivariate modeling of proteins related to trapezius myalgia, a comparative study of female cleaners with or without pain. PLoS One. 2013;8(9):e73285.
  • Hadrévi J, Turkina M, Carlsson A, et al. Myosin light chain and calcium regulating protein differences in chronic musculoskeletal neck and shoulder pain. J Integr OMICS. 2016;6(1):1–8.
  • Olausson P, Gerdle B, Ghafouri N, et al. Protein alterations in women with chronic widespread pain–An explorative proteomic study of the trapezius muscle. Sci Rep. 2015;5:11894.
  • Bazzichi L, Ciregia F, Giusti L, et al. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl. 2009;3(11):1296–1304.
  • Ruggiero V, Era B, Cacace E, et al. A preliminary study on serum proteomics in fibromyalgia syndrome. Clin Chem Lab Med. 2014;52(9):e207–10.
  • Wåhlén K, Olausson P, Carlsson A, et al. Systemic alteration of plasma proteins from women with chronic widespread pain compared to healthy controls; a proteomic study. J Pain Res. 2017;10:797–809.
  • Ghafouri B, Carlsson A, Holmberg S, et al. Biomarkers of systemic inflammation in farmers with musculoskeletal disorders; a plasma proteomic study. BMC Musculoskelet Disord. 2016;17(1):206.
  • Olausson P, Ghafouri B, Backryd E, et al. Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women - a multivariate explorative cross-sectional study. J Pain Res. 2017;10:575–590.
  • Khoonsari PE, Ossipova E, Lengqvist J, et al. The human CSF pain proteome. J Proteomics. 2019;190:67–76.
  • Backryd E, Edstrom S, Gerdle B, et al. Do fragments and glycosylated isoforms of alpha-1-antitrypsin in CSF mirror spinal pathophysiological mechanisms in chronic peripheral neuropathic pain? An exploratory, discovery phase study. BMC Neurol. 2018;18(1):116.
  • Pattini L, Mazzara S, Conti A, et al. An integrated strategy in two-dimensional electrophoresis analysis able to identify discriminants between different clinical conditions. Exp Biol Med (Maywood). 2008;233(4):483–491.
  • Cannistraci CV, Ravasi T, Montevecchi FM, et al. Nonlinear dimension reduction and clustering by minimum curvilinearity unfold neuropathic pain and tissue embryological classes. Bioinformatics. 2010;26(18):i531–9.
  • Yuan X, Russell T, Wood G, et al. Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis. 2002;23(7–8):1185–1196.
  • Lim TKY, Anderson KM, Hari P, et al. Evidence for a role of nerve injury in painful intervertebral disc degeneration: a cross-sectional proteomic analysis of human cerebrospinal fluid. J Pain. 2017;18(10):1253–1269.
  • Olausson P, Ghafouri B, Ghafouri N, et al. Specific proteins of the trapezius muscle correlate with pain intensity and sensitivity - an explorative multivariate proteomic study of the trapezius muscle in women with chronic widespread pain. J Pain Res. 2016;9:345–356.
  • Wåhlén K, Ghafouri B, Ghafouri N, et al. Plasma protein pattern correlates with pain intensity and psychological distress in women with chronic widespread pain. Front Psychol. 2018;9:2400.
  • Bazzichi L, Da Valle Y, Rossi A, et al. A multidisciplinary approach to study the effects of balneotherapy and mud-bath therapy treatments on fibromyalgia. Clin Exp Rheumatol. 2013;31(6 Suppl 79):S111–20.
  • Lind AL, Emami Khoonsari P, Sjodin M, et al. Spinal cord stimulation alters protein levels in the cerebrospinal fluid of neuropathic pain patients: a proteomic mass spectrometric analysis. Neuromodulation. 2016;19(6):549–562.
  • Cominetti O, Nunez Galindo A, Corthesy J, et al. Obesity shows preserved plasma proteome in large independent clinical cohorts. Sci Rep. 2018;8(1):16981.
  • Lau B, Gange SJ, Moore RD. Interval and clinical cohort studies: epidemiological issues. AIDS Res Hum Retroviruses. 2007;23(6):769–776.
  • Bromley Milton M, Borsbo B, Rovner G, et al. Is pain intensity really that important to assess in chronic pain patients? A study based on the swedish quality registry for pain rehabilitation (SQRP). PLoS One. 2013;8(6):e65483.
  • Backryd E, Persson EB, Larsson AI, et al. Chronic pain patients can be classified into four groups: clustering-based discriminant analysis of psychometric data from 4665 patients referred to a multidisciplinary pain centre (a SQRP study). PLoS One. 2018;13(2):e0192623.
  • Gerdle B, Åkerblom S, Brodda Jansen G, et al. Who benefit from multimodal rehabilitation – an exploration of pain, psychological distress and life impacts in over 35 000 chronic pain patients identified in the Swedish quality registry for pain rehabilitation (SQRP). J Pain Res. 2019;12:891–908.
  • Gerdle B, Åkerblom S, Stålnacke B-M, et al. The importance of emotional distress, cognitive behavioural factors and pain for life impact at baseline and for outcomes after rehabilitation – a SQRP study of more than 20 000 chronic pain patients. Scand J Pain. 2019;19(4):693–711.
  • Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106(3):337–345.
  • Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1–2):9–19.
  • Kaiser U, Kopkow C, Deckert S, et al. Developing a core outcome-domain set to assessing effectiveness of interdisciplinary multimodal pain therapy: the VAPAIN consensus statement on core outcome-domains. Pain. 2018;159(4):673–683.
  • Lamers F, Bot M, Jansen R, et al. Serum proteomic profiles of depressive subtypes. Transl Psychiatry. 2016;6(7):e851.
  • Dahl J, Ormstad H, Aass HC, et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology. 2014;45:77–86.
  • Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457.
  • Lee J, Joo EJ, Lim HJ, et al. Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses. Psychiatry Investig. 2015;12(2):249–259.
  • Ruland T, Chan MK, Stocki P, et al. Molecular serum signature of treatment resistant depression. Psychopharmacology (Berl). 2016;233(15–16):3051–3059.
  • Dong HJ, Larsson B, Levin LA, et al. Is excess weight a burden for older adults who suffer chronic pain? BMC Geriatr. 2018;18(1):270.
  • Bruderer R, Muntel J, Muller S, et al. Analysis of 1508 plasma samples by capillary-flow data-independent acquisition profiles proteomics of weight loss and maintenance. Mol Cell Proteomics. 2019;18(6):1242–1254.
  • Alfoldi P, Wiklund T, Gerdle B. Comorbid insomnia in patients with chronic pain: a study based on the Swedish quality registry for pain rehabilitation (SQRP). Disabil Rehabil. 2014;36(20):1661–1669.
  • Santos-Lozano A, Valenzuela PL, Llavero F, et al. Successful aging: insights from proteome analyses of healthy centenarians. Aging (Albany NY). 2020;12(4):3502–3515.
  • Danese E, Montagnana M, Lippi G. Proteomics and frailty: a clinical overview. Expert Rev Proteomics. 2018;15(8):657–664.
  • Ubaida-Mohien C, Lyashkov A, Gonzalez-Freire M, et al. Discovery proteomics in aging human skeletal muscle finds change in spliceosome, immunity, proteostasis and mitochondria. Elife. 2019;8. DOI:10.7554/eLife.49874
  • Gianazza E, Miller I, Guerrini U, et al. Gender proteomics I. Which proteins in non-sexual organs. J Proteomics. 2018;178:7–17.
  • Gemmati D, Varani K, Bramanti B, et al. Bridging the Gap” Everything that could have been avoided if we had applied gender medicine, pharmacogenetics and personalized medicine in the gender-omics and sex-omics era. Int J Mol Sci. 2020;21(1):296.
  • Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10(5):447–485.
  • Gerdle B, Bjork J, Henriksson C, et al. Prevalence of current and chronic pain and their influences upon work and healthcare-seeking: a population study. J Rheumatol. 2004;31(7):1399–1406.
  • Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. 2013;111(1):52–58.
  • Unruh AM. Gender variations in clinical pain experience. Pain. 1996;65(2–3):123–167.
  • Hernandez B, Parnell A, Pennington SR. Why have so few proteomic biomarkers “survived” validation? (Sample size and independent validation considerations). Proteomics. 2014;14(13–14):1587–1592.
  • Lualdi M, Fasano M. Statistical analysis of proteomics data: a review on feature selection. J Proteomics. 2019;198:18–26.
  • Davis KD, Cheng JC. Differentiating trait pain from state pain: a window into brain mechanisms underlying how we experience and cope with pain. Pain Rep. 2019;4(4):e735.
  • Eriksson L, Byrne T, Johansson E, et al. Multi- and megavariate data analysis: basic principles and applications. Malmö: MKS Umetrics AB; 2013.
  • Gerdle B, Backryd E, Falkenberg T, et al. Changes in inflammatory plasma proteins from patients with chronic pain associated with treatment in an interdisciplinary multimodal rehabilitation program - an explorative multivariate pilot study. Scand J Pain. 2019;20(1):125–138.
  • Hysing EB, Smith L, Thulin M, et al. Detection of systemic inflammation in severely impaired chronic pain patients and effects of a multimodal pain rehabilitation program. Scand J Pain. 2019;19(2):235–244.
  • Rosendal L, Larsson B, Kristiansen J, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain. 2004;112(3):324–334.
  • Gerdle B, Ernberg M, Mannerkorpi K, et al. Increased interstitial concentrations of glutamate and pyruvate in vastus lateralis of women with fibromyalgia syndrome are normalized after an exercise intervention - a case-control study. PLoS One. 2016;11(10):e0162010.
  • Gerdle B, Larsson B, Forsberg F, et al. Chronic widespread pain: increased glutamate and lactate concentrations in the trapezius muscle and plasma. Clin J Pain. 2014;30(5):409–420.
  • Bäckryd E, Lind AL, Thulin M, et al. High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls. Pain. 2017;158(12):2487–2495.
  • Nosek BA, Errington TM. What is replication? PLoS Biol. 2020;18(3):e3000691.
  • Jin P, Lan J, Wang K, et al. Pathology, proteomics and the pathway to personalised medicine. Expert Rev Proteomics. 2018;15(3):231–243.
  • Jasim H, Carlsson A, Gerdle B, et al. Diurnal variation of inflammatory plasma proteins involved in pain. Pain Rep. 2019;4(5):e776.
  • Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Biotechnol. 2003;21(3):255–261.
  • Jiang J, Wang K, Chen Y, et al. Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy. Signal Transduct Target Ther. 2017;2:17036.